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ABSTRACT 23!
Background: SPARC/Osteonectin is an evolutionarily conserved matricellular protein that 24!
modulates cell-matrix interaction and cell function. In all vertebrates, SPARC is dynamically 25!
expressed during embryogenesis. However, the precise function of SPARC and the regulatory 26!
elements required for its expression in particular during early embryogenesis are largely 27!
unknown. Results: The present study was undertaken to explore the molecular mechanisms that 28!
regulate sparc gene expression by in-vivo functional characterization of the sparc promoter and 29!
identification of possible putative regulatory elements that govern basal promoter activity. We 30!
report here transient expression analyses of eGFP expression from transgenic zebrafish 31!
containing a Sparc-iTol2-eGFP-BAC and/or 7,25kb-sparc-Tol2-eGFP constructs. eGFP 32!
expression was specifically found in the notochord, otic vesicle, fin fold, intermediate cell mass 33!
and olfactory placode of BAC and Tol2 transposon vectors injected embryos. Deletion analysis 34!
revealed that promoter activity resides in the unique 5′-UTR intronic region. Computer-based 35!
analysis revealed a putative CpG island immediately proximal to the translation start site within 36!
the intron sequence. Global inhibition of methylation with 5-Aza-2-deoxycytidine promoted 37!
sparc expression in association with decreasing CpG methylation. Conclusion: Taken together, 38!
these data identify a contributory role for DNA methylation in regulating sparc expression in 39!
zebrafish embryogenesis. 40!
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INTRODUCTION 43!
SPARC (secreted protein acidic and rich in cysteine), also named osteonectin or BM-40, is a 44!
non-structural component of the extracellular matrix that it is thought to modulate cell–matrix 45!
interactions, particularly during tissue remodelling and at sites of high cellular turnover during 46!
development, wound-healing and carcinogenesis. SPARC is spatially and temporally regulated 47!
during development and displays a high degree of sequence conservation (Laize et al., 2005; 48!
Rotllant et al., 2008), indicating a conserved, essential functional role in vertebrates. We have 49!
previously shown that the zebrafish sparc gene is also expressed in a temporally and spatially 50!
specific manner, with strong expression in the developing inner ear and pharyngeal cartilage 51!
(Rotllant et al., 2008). We showed further that sparc interacts with genes in known genetic 52!
networks, unveiling its novel functions in regulating pharyngeal cartilage and inner ear 53!
development. We also demonstrated a critical role of Sparc in embryonic haematopoiesis during 54!
early development of zebrafish (Ceinos et al., 2013). Specifically, we showed that sparc is a 55!
modulator of lineage-specific transcription factor gata 1 expression levels or activity.  56!
Furthermore, we demonstrated a UV exposure-dependent increase in the expression of the 57!
matricellular protein osteonectin in zebrafish embryos (Torres-Nuñez et al., 2012). Therefore, 58!
because of its spatially and temporally regulated expression during development and its 59!
multifunctional role, sparc gene is expected to be tightly regulated. Although isolation of sparc 60!
promoter regions from different species has been reported (Mcvey et al., 1988; Young et al., 61!
1989; Damjonovski et al., 1998), little is known about regulation of sparc gene expression at the 62!
transcriptional level during embryogenesis. It has been shown that the 5’ flanking region of the 63!
sparc gene contains cis-regulatory elements that might be responsible for differential expression 64!
during normal development in different vertebrate species. Possible regulatory sequences found 65!
on sparc promoter include GATA factor binding sites, growth hormone consensus sequences, 66!
heat shock factors, metal responsive elements, NF1 and SP1 binding and myogenic elements. 67!
Another important class of regulatory regions, the so-called CpG islands, has also been found in 68!
sparc promoter regions (Yang et al., 2007; Gao et al., 2010).  CpG islands are specific regions of 69!
200 base pairs (bp) with over 50% G+C content and a CpG frequency of 0.6 (observed/expected 70!
ratio) susceptible to transcriptional gene regulation by DNA methylation. Therefore, aberrant 71!
methylation of sparc promoter has been associated with disc degeneration (Tajerian et al., 2011) 72!
and pancreatic, colorectal and ovarian cancers (Cheetham et al., 2008; Socha et al., 2009; Gao et 73!
al., 2010). In summary, although numerous factors appear to be involved in transcriptional 74!
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regulation of the sparc gene, detailed information on the molecular mechanisms regulating sparc 75!
gene activity is still lacking, and a consistent promoter study has not yet been performed in non-76!
mammalian vertebrates, particularly teleosts, although it has been shown that they apparently 77!
have less SPARC or SPARCL1 functional homologues than mammals. Therefore, observations 78!
in non-mammalian vertebrates might reveal key functions of SPARC and its regulatory 79!
mechanisms. 80!
The present study was undertaken to explore the molecular mechanisms that regulate sparc gene 81!
expression by in-vivo functional characterization of the sparc promoter and identification of 82!
possible putative regulatory elements that govern basal promoter activity. Specifically, the 83!
investigation was focused on the occurrence and role of CpG dinucleotides methylation in the 84!
sparc putative promoter sequence and on a possible epigenetic level of regulation of sparc 85!
expression in fish. 86!
 87!
RESULTS 88!
 89!
Analysis of 5’-untranslated region of sparc sequence in zebrafish  90!
The 5’UTR of sparc was characterized by RACE. The start of transcription was found to be 91!
separated from the start of translation by a 7-kb intron (Fig. 1A). The whole 5’UTR sequence 92!
comprises 138 nucleotides, of which 13 correspond to the region proximal to the sparc ATG in 93!
exon 2. Therefore, the non-coding exon I contains 125 bp, while exon II contains 70 bp (13 pb 94!
from the untranslated region plus 57 bp from the coding sequence).  95!
 96!
Functional analysis of the putative promoter region of sparc gene in zebrafish 97!
Functional analysis of the putative promoter region of zebrafish sparc was done through 98!
expression of eGFP. BAC clone (number 97O1) (190Kb) from DanioKey zebrafish BAC library 99!
containing the sparc gene (Fig.1B) was used to explore the putative sparc promoter activity. 100!
Additionally, to particularly assess whether the 5′-flanking region of the sparc gene could 101!
support transcription, the 0.25 kb sparc promoter and its 5'-flanking sequence 7 kb upstream of 102!
the translated exon 2 were linked with the eGFP reporter gene (Fig. 1C). To identify the key 103!
regulatory region within the P2 construct sequence responsible for sparc expression, a third 104!
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construct similar to construct P2 but lacking the UTR intron (+126/+7168) (Fig.1D) was also 105!
generated (Tol2-0,25kb-sparc-eGFP; P3 construct). The resulting gene constructs, Sparc-iTol2-106!
eGFP-BAC (P1), 7,25kb-sparc-Tol2-eGFP (P2) and 0,25kb-sparc-Tol2-eGFP (P3) were 107!
microinjected into zebrafish embryos for transient expression analysis. eGFP expression in 108!
injected embryos was monitored by direct observation under a confocal fluorescence 109!
microscope. The promoter activities of P1 and P2 reporter gene constructs are shown in Fig. 2. 110!
eGFP expression was initially observed at 19 hpf in the notochord (Fig. 1E). At 30 hpf, strong 111!
eGFP expression was seen in the otic vesicle, pharyngeal region, caudal fin fold and in the 112!
hematopoietic ICM region (Fig.1F,G,H). At 48 hpf, strong eGFP expression was seen in the 113!
olfactory placode, specifically in the olfactory sensory neurons (Fig. 1I). Observed eGFP 114!
expression from transient expression of Sparc-iTol2-eGFP-BAC (P1 construct) and Tol2-7,25kb-115!
sparc-eGFP (P2 construt) constructs were equivalent. The P3 construct containing only the 116!
proximal promoter and the 5’ untranslated region of exon 1 (-127bp/+125bp) did not express 117!
eGFP, indicating that removal of the 5’UTR-intron (nt+126/+7168) resulted in complete 118!
reduction of promoter activity.  119!
To determine whether the endogenous sparc gene was specifically expressed in the same 120!
domains, in situ hybridization was performed with a sparc antisense probe (2) in zebrafish 121!
embryos. Sparc mRNA was indeed expressed in almost all the same domains as in transient 122!
eGFP expression studies (Fig. 1J,K,L). Therefore, eGFP expression in the Sparc-iTol2-eGFP-123!
BAC and Tol2-7,25kb-sparc-eGFP constructs injected fish mostly recapitulated the endogenous 124!
expression pattern of sparc mRNA (2). 125!
These data indicated that the 0.25-kb sparc promoter and its 5'-flanking sequence 7 kb upstream 126!
of the translated exon contained the regulatory element(s) that temporally and dynamically drive 127!
tissue-specific expression in the notochord, pharyngeal region, otic vesicle, intermediate cell 128!
mass, fin fold and olfactory sensory neurons.  129!
On the basis of our finding that the 5’UTR-intron +126bp to +7168 bp region is key to the 130!
transcriptional regulation of sparc, we sought to identify possible putative regulatory elements 131!
that could be involved in this regulation. Using Computer base-analysis, we identified that the 132!
+6634 to +6905 region within the sparc 5′-UTR intron 1 sequence display all the characteristic 133!
signatures of a genomic CpG island; therefore we hypothesized a role of CpG dinucleotide 134!
methylation in the regulation of sparc expression. 135!
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In addition, using the MatInspector database, we also identified several putative transcription 136!
factor binding sequences in the (+126/+7168) region, including sites for heat shock elements, 137!
cAMP responsive element binding proteins, gata factors, sox factors, myoblasts factors, 138!
glucocorticoid response elements, retinoic acid receptors and activating protein-1. These putative 139!
regulators have been shown to be involved in sparc transcriptional regulation in other species, 140!
but most were located upstream the initial transcription site instead of the intronic sequence as 141!
we found in zebrafish (Young et al., 1989; Damjanovski et al., 1998).  Moreover, zebrafish sparc 142!
promoter lacks both the consensus CAAT box and TATA box, elements usually associated with 143!
developmentally regulated genes. 144!
 145!
Experimentally induced 5-Aza-2-deoxycytidine DNA hypomethylation 146!
As we detected a CpG island immediately proximal to the translation start site in the intron (i1-2) 147!
sequence (Fig.1A), we hypothesized a role of CpG dinucleotide methylation in the regulation of 148!
sparc expression. Therefore, to investigate the relationship between sparc transcriptional 149!
activation and CpG methylation, we treated developing zebrafish larvae with 50 µM 5-Aza-2-150!
deoxycytidine (5-aza-dC) starting at 11 dpf. Larvae were examined at the end of treatment, at 40 151!
dpf. Approximately 40% of 5-aza-dC-treated larvae showed distinctive phenotypic 152!
abnormalities, with a shortened tail, torsion of the spinal cord, head malformations and 153!
depigmentation (data not shown).  154!
In order to verify the experimentally induced global inhibition of methylation with 5-aza-dC, 155!
samples from untreated and 5-aza-dC-treated fish were MSAP genotyped. The number of loci 156!
obtained for the primer combination used in this experiment was 423, of which 355 were 157!
classified as methylation-susceptible loci. The percentage of polymorphic methylation-158!
susceptible loci was 63%, and the mean Shannon’s diversity index was 0,598 ± 0,101. The 159!
proportions of the four methylation states (unmethylated, hemi-methylated, internal cytosine 160!
methylation and full methylation) are shown in Table 2. The major difference between groups, 161!
25%, was detected for the unmethylated state, the 5-aza-dC-treated fish showing 41.6% 162!
demethylation and the control fish 16.6%. The percentage internal cytosine methylation and full 163!
methylation states were higher in the control group, and small difference was seen for the hemi-164!
methylated state. The differences between groups in genome-wide methylation were statistically 165!
significant (AMOVA; Φst= 0.5232, p < 0.0001). In the principal coordinates analysis, the control 166!
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group was clearly separated from the 5-aza-dC-treated group along the first coordinate (44.1% of 167!
variance explained) (Fig. 2). The two groups were also differentiated along the second 168!
coordinate, with 10.1% of variance explained. These data support the use of 5-Aza-2-169!
deoxycytidine as a demethylating agent in zebrafish larvae. 170!
 171!
Global inhibition of methylation with 5-Aza-2-deoxycytidine promoted sparc 172!
transcriptional activation in association with decreasing CpG methylation. 173!
To determine more specifically the methylation status of the CpG sites in the +6634 to +6905 nt 174!
region upstream of the sparc translation starting site and included in first intron (i1-2) (Fig. 3A), 175!
bisulfite-treated DNA from control and 5-aza-dC-treated fish was sequenced. 176!
Exposure to 5-aza-dC decreased sparc CpG island methylation from 57.3±3.48 to 22.4±5.17 % 177!
in control and treated fish, respectively (t = 4.153, p = 0.001) (Fig. 3B). Significant differences in 178!
eight of nine positions were detected between treated and untreated fish, positions +6661 and 179!
+6705 showing the most significant differences (t = 2.381, p = 0.004 and t = 4.394; p = 0.003, 180!
respectively). Significant differences in sparc gene expression were also seen according to 181!
treatment (Fig.1S). Sparc levels were increased in fish treated with 5-aza-dC by up to threefold 182!
in respect of control fish (t = -4.86; p = 0.001) (Fig. 1S). Therefore, global inhibition of 183!
methylation with 5-aza-dC promoted sparc expression in association with decreasing CpG 184!
methylation.  185!
 186!
Methylation of whole plasmid containing the sparc 7,25kb upstream promoter driving the 187!
eGFP reporter gene suppresses transcription. 188!
As described before, the major activity of the sparc promoter seems to be contained within the 189!
5’UTR-intron sequence, lying between +126bp to +7168 bp from the transcription start site. 190!
Therefore, the P2 construct was methylated in vitro by Sss I methylase which specifically 191!
methylates the cytosine in the dinucleotide sequence 5’-CG-3’. This methylation pattern closely 192!
mimics that found in the genomic DNA.  In vitro methylation of the Tol2-7,25kb-sparc-eGFP 193!
(P2 construct) containing the 0.25-kb Sparc promoter and its 5'-flanking sequence 7 kb upstream 194!
of the translated exon 2 resulted in an approximately 4-fold decrease in eGFP fluorescence (Fig. 195!
4A,B,E).  To avoid the possible interfering methylation of backbone CpGs, the CpG free 196!
mustn1b promoter (data non-published) was ligated into the pToleGFPDest vector (Lawson Lab 197!
# 274), SssI methylated and microinjected. Zebrafish mustn1b (Mustang 1b, musculoskeletal 198!
temporally activated novel gene) promoter specifically drives the eGFP expression in the 199!
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skeletal muscle. In vitro methylation of the Tol2-0.75Kb-mustn1b-eGFP construct containing the 200!
0.75-kb CpG free mustn1b promoter had no effect in the mustn1b promoter activity (Fig. 201!
4A,B,E). Suggesting therefore, that complete methylation of the vector backbone, had a 202!
negligible effect on transcription from both promoters (Fig. 4). 203!
 204!
DISCUSSION 205!
SPARC is a highly conserved extracellular matrix protein, which is actively involved, in many 206!
cellular processes including development, wound healing, angiogenesis, tumorogenesis and 207!
inflammation. This critical role of SPARC in a variety of different biological processes imposes 208!
a tight control of its transcriptional regulation. Although isolation of sparc promoter regions 209!
from different species has been reported (McVey et al., 1988; Young et al., 1989; Damjanovski 210!
et al., 1998) and numerous factors appear to be involved in its transcriptional regulation, detailed 211!
information on the molecular mechanisms regulating sparc gene activity is still lacking, and a 212!
consistent promoter study has not yet been performed in non-mammalian vertebrates. 213!
In this study, we investigated sparc gene expression and the regulatory elements required for its 214!
expression in particular during early embryogenesis by using transient expression analyses in 215!
zebrafish embryos. Comparative molecular analysis of sparc promoter and its 5'-flanking 216!
sequence between zebrafish and other vertebrate species showed no nucleotide homology at the 217!
5’ ends (Damjanovski et al., 1998). However, a number of similarities in their overall 218!
organization were found (Young et al., 1989). Thus, the molecular organization of the first and 219!
second exons is conserved. Exon I, containing 125 bp in zebrafish, represents the majority of the 220!
5’ untranslated region in zebrafish and other vertebrate species (McVey et al., 1988; Young et 221!
al., 1989; Damjanovski et al., 1998), while exon II, which comprises 70bp in zebrafish, contains 222!
the remainder of the 5’ untranslated region and encodes the entire signal peptide like other 223!
vertebrates species. Another characteristic found in zebrafish and other vertebrate species is the 224!
presence of the 5’CCTG3’ motif in the sparc promoter and its 5'-flanking sequence. The function 225!
of this conserved sequence has been shown to be important in either regulation on the gene or the 226!
stability of RNA (McVey et al., 1988). A common characteristic of sparc gene organization in 227!
all vertebrates species studied is the presence of an intronic sequence between the first non-228!
coding and the second coding exon. However, the size of the first intron seems to be species-229!
specific, being 7 kb in zebrafish, 10 kb in humans and 2 kb in Xenopus (Damjanovski et al., 230!
1998). Similar to mammalian vertebrates, the promoter of sparc gene in zebrafish lacks the 231!
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classical CAAT and TATA box motifs found in many eukaryotic promoters. We found that the 232!
0.2-kb sparc promoter and its 5' flanking sequence 7 kb upstream of the translated exon drive 233!
eGFP expression in the notochord, otic vesicle, pharyngeal region, fin fold and intermediate cell 234!
mass, which mimicked the already well described expression pattern of the endogenous sparc 235!
mRNAs (Laize et al., 2005; Rotllant et al., 2008). Similar results were found in mice, where 236!
sparc transcripts were detected in developing tissues, such as the otic vesicle (Mothe et al., 237!
2001), notochord and embryonic skeleton (Mason et al., 1986; Holland et al., 1987). In addition, 238!
the 0.2-kb sparc promoter and its 5'-flanking sequence 7 kb upstream of the translated exon 239!
drove the eGFP expression in the olfactory placode, specifically in the olfactory sensory 240!
neurons. Although specific expression of sparc in the olfactory bulb of mice has already been 241!
reported (Mendis et al., 1994), this is the first demonstration of the expression of sparc in the 242!
olfactory sensory neurons of the olfactory epithelium in non-mammalian vertebrate. We were 243!
unable to detect sparc expression in the olfactory placode by whole-mount in-situ hybridization. 244!
One possible explanation may be the limited sensitivity of our assay to detect faint expression of 245!
sparc in some regions. It should also be noted that, although the conclusion was based on 246!
transient expression analysis, it is unlikely that the tissue-specific spatial expression pattern of 247!
the eGFP was due to a position effect of the integration site, because the pattern of eGFP 248!
expression mimicked endogenous sparc expression in many ways. However, we cannot exclude 249!
the possibility that there might be a position effect on the activity of the promoter, which might 250!
explain the specific eGFP expression in the olfactory sensory neurons in mosaic fish. 251!
Transient expression analyses in zebrafish embryos demonstrated that promoter activity resides 252!
in the unique 5′-UTR intronic region (nt+126/+7168). Specific deletion of this region resulted in 253!
a complete reduction of promoter activity. Transcriptional regulation of other genes (such as 254!
ubiquitine C) has also been shown to be exclusively regulated by the 5’UTR intron sequence 255!
(Bianchi et al., 2009). Therefore, the 5′-UTR unique intronic region (nt+126/+7168) provides the 256!
regulatory elements required for expression of a reporter gene in a subset of tissues that normally 257!
express the endogenous sparc gene in zebrafish embryos.  258!
Sequence analyses of the zebrafish sparc 5′-UTR intron 1 region revealed a number of 259!
transcription factor binding sites. Because of the similarities in the overall organization of the 260!
sparc promoter and sparc expression domains and the highly conserved amino acid sequence in 261!
diverse vertebrate species (Laize et al., 2005), we compared conservation of cis-acting genetic 262!
elements that regulate sparc expression in the zebrafish 5′-UTR intron 1 sequence. Several 263!
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transcription factors in zebrafish were common to other sparc promoter sequences, including 264!
heat shock elements, cAMP- responsive element binding proteins, myoblast factors, gata binding 265!
factors, activating protein 1, retinoic acid receptor and glucocorticoid elements. All these factors 266!
have been shown to regulate sparc expression in vitro (Brekken and Sage, 2000). Additionally, 267!
transcription factor binding sites belonging to the Sox family were identified in the zebrafish 5′-268!
UTR intron 1 region. This finding is in agreement with several other studies showing the role of 269!
SOX elements in sparc transcriptional regulation (Rotllant et al., 2008; Huang et al., 2008). 270!
A CpG-rich sequence (CpG island) was also identified in the zebrafish 5′-UTR intron 1 region. It 271!
has been shown that sparc is transcriptionally regulated by DNA methylation, and CpG-rich 272!
sequences were also identified in mammalian SPARC promoter sequences (Rodriguez-Jimenez 273!
et al., 2007; Gao et al., 2010; Tajerian et al., 2011). In order to obtain insights into the 274!
transcriptional regulation of sparc expression, we investigated the role of DNA methylation in 275!
the expression of sparc in zebrafish embryos. 5-aza-dC was used to artificially induce DNA 276!
hypomethylation. This method has already been used to induce aberrant DNA hypomethylation 277!
in zebrafish embryos (Martin et al., 1999; Christman, 2002). Our results show that (i) exposure 278!
to 5-aza-dC produces distinctive phenotypic abnormalities in zebrafish larvae, including 279!
shortened tail, torsion of spinal cord, head malformations and depigmentation (data not shown); 280!
(ii) exposure to 5-aza-dC produces significant global DNA demethylation in zebrafish larvae; 281!
(iii) exposure to 5-aza-dC specifically reduced CpG-rich sequence (CpG island) methylation in 282!
the zebrafish sparc 5′-UTR intron 1 region; and (iv) sparc is highly expressed in 5-aza-dC 283!
treated zebrafish larvae.  Additionally, we also show that in vitro methylation of the sparc gene 284!
promoter is capable of attenuating transcription in zebrafish embryos. Taken together, these data 285!
identify a contributory role for DNA methylation in regulating sparc expression in zebrafish 286!
embryogenesis. 287!
In summary, our study provides the first evidence that the 5′-UTR intron of zebrafish sparc gene 288!
contains the functional and regulatory elements required for its expression, in particular during 289!
early embryogenesis. We also provide evidence that sparc is transcriptionally regulated by DNA 290!
methylation. Our findings should provide a basis for further studies to characterize critical 291!
regulatory elements and to elucidate the molecular mechanisms underlying transcriptional 292!
regulation of the sparc gene under both physiological and pathological conditions.  293!
 294!
EXPERIMENTAL PROCEDURES 295!
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Experimental animals 296!
Zebrafish embryos were cultured as previously described (Westerfield, 2007) and staged by 297!
standard criteria Kimmel et al., 1995) or by hours (hpf) or days (dpf) post fertilization. 298!
Experiments were performed with the TU (Tuebingen) wild-type strain (Nüsslein-Volhard 299!
Laboratory). To inhibit embryo pigmentation, embryo medium was supplemented with 0.003% 300!
(w/v) 2-phenylthiourea (Westerfield, 2007). For histology, dechorionated embryos were fixed 301!
overnight at 4 °C in 4% paraformaldehyde in 1XPBS, washed in PBS, and either stored at 4 °C 302!
in 1XPBS for confocal imaging or dehydrated through a methanol series and stored at -20 °C in 303!
100% methanol for in situ hybridization. Ethical approval for all studies was obtained from the 304!
Institutional Animal Care and Use Committee of the IIM-CSIC Institute in accordance with the 305!
National Advisory Committee for Laboratory Animal Research Guidelines licensed by the 306!
Spanish Authority (1201/2005) and conformed to European animal directive (86/609/EEC) for 307!
the protection of experimental animals. 308!
 309!
Determination of transcription start site by 5-RACE 310!
RACE was carried out to determine the transcription start site according to the instructions 311!
provided by SMART RACE cDNA Amplification Kit (BD Bioscience, Clontech Laboratory). 312!
5’-RACE-Ready cDNA was amplified with the adapter primer (see manual protocol) and a 5’ 313!
gene specific primer (5’- GCCAGCGAGGCAGAACAGGAAGAAG -3’). The polymerase 314!
chain reaction (PCR) product was subcloned into the pGEM-T easy vector for sequencing. 315!
 316!
Construction of BAC and Tol2 transposon vectors 317!
BAC Clone (number 97O1) from DanioKey zebrafish BAC library containing the sparc gene 318!
was purchased from Source BioScience, UK. The constructions of Sparc-iTol2-eGFP BAC 319!
DNA vector was carried out essentially as previously described (Suster et al., 2009). To generate 320!
the Sparc- iTol2 BAC clone, we used recombineering in Escherichia coli to introduce the iTol2-321!
amp cassette from pCR8GW-iTol2-amp plasmid (Suster et al., 2009) in the BAC plasmid 322!
backbone, which contains the inverted minimal cis-sequences required for Tol2 transposition. 323!
The insertion of the reporter gene eGFP into the sparc locus of sparc-iTol2 BAC clone was 324!
carried out using homologous recombination. Briefly, eGFP-kan reporter gene cassette from 325!
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linear double-stranded eGFP-pA-FRT-kan-FRT plasmid was amplified by PCR, together with 326!
50-bp homologies to the sparc translation start site. After transformation of sparc-iTol2 BAC 327!
clone-containing cells with the PCR product, homologous recombination took place between the 328!
PCR product and the sparc-iTol2 BAC clone resulting in integration of the vector insert into the 329!
BAC clone, placing the eGFP reporter gene under control of the sparc promoter within the clone 330!
(sparc-iTol2-eGFP-BAC) (P1)(Figure.1B). 331!
The zebrafish sparc promoter sequences (GenBank accession number: BX640507) for the Tol2 332!
transposon constructs used in this study were amplified from DanioKey zebrafish genomic BAC 333!
library clone number 97O1 (Source BioScience, UK) with KOD Xtremetm Hot Start DNA 334!
Polymerase Platinum (Novagen, 71975). The PCR conditions were: 94 ºC for 2 min and 40 335!
cycles with a 10-s denaturation step at 98 ºC, 55 ºC for 30 s and 68 ºC for 10 min. The primers 336!
used were 5’AAGCTTAGCACAATAGGATG -3’ and 5’-337!
TTTTGCTTAGGCTGAAACTCAAG-3’. The agarose band was extracted and purified with the 338!
QIAquick® Gel Extraction Kit. The PCR product was diluted 1:10, and 1 µl was ligated into 339!
1 µl of P-ENTRTm /D-TOPO® Cloning Kit (Invitrogen) and transformed according to the 340!
protocol. Both promoter sequences were then ligated by LR clonase into the destination vector 341!
pToleGFPDest (Lawson Lab # 274) containing the eGFP sequence downstream, and sequenced. 342!
Construct P2 (7,25kb-sparc-Tol2-eGFP) contains 127 nt upstream to the transcription start 343!
(herein referred to as the proximal promoter, PP), the 125 nt of exon 1, the 7043 nt of intron 1 344!
and the 13 nt of exon 2, excluding the translation starting site (+7182) (Figure. 1C). Construct P3 345!
(0,25kb-sparc-Tol2-eGFP) was similar to construct P2, except that it lacked the UTR intron 346!
(+126/+7168) (Figure 1C). Cis-Acting transcription factor binding sites located in the zebrafish 347!
sparc promoter sequence were identified with MatInspector software (Cartharius et al., 2005). 348!
CpG island predictor analyses were done with MethPrimer software (Li et al., 2002). 349!
 350!
Analysis of eGFP reporter gene expression 351!
BAC construct DNA and Tol2 constructs were dissolved in distilled RNAase free H2O to a final 352!
concentration of 200 ng/µL and 50 µg/ml respectively. Approximately 2 nl of DNA solution with 353!
transposase mRNA (200 ng/µL and 60 µg/ml respectively) were microinjected into the 354!
cytoplasm of zebrafish embryos at the one- or two-cell stage. Microinjection was carried out 355!
under a dissection microscope (MZ8, Leica) fitted with a MPPI-2 pressure injector (ASI 356!
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systems). eGFP expression in the injected embryos was analysed at 19, 24, 48 and 72 h post 357!
fertilization (hpf). eGFP expression was analysed by direct observation of eGFP expression 358!
under a fluorescence stereoscope and a confocal microscope. The number of embryos showing 359!
eGFP fluorescence was determined and the BAC and Tol2 vector constructs were compared to 360!
score activity and tissue specificity.  361!
 362!
In situ hybridization 363!
Whole-mount in situ hybridization was performed with digoxigenin-labelled antisense probes as 364!
previously described (Rotllant et al., 2008). Antisense riboprobes were made from linearized 365!
full-length Danio rerio sparc cDNA (GenBank Accession number: BC071436) (primers: 366!
forward 5’-TGCTTAGGCTGAAACTCAAGATGAG-3’; reverse 5’-367!
GCATCAATGGAAGACGTCCTTAGAT-3’). 368!
 369!
In vitro methylation reactions 370!
Whole reporter gene plasmids were in vitro methylated using Sss1 methylase (New England 371!
BioLabs) following the manufacturer’s protocol. Sss1 methylation was performed with 10 mM 372!
Tris, pH 7.9, 50 mM NaCl, 10 mM MgCl2, 1 mM DTT, and 160 mM S-adenosylmethionine at 373!
37°C for 1 h. Successful vector methylation was checked by analyzing band patterns on gel 374!
electrophoresis after digestion of the purified plasmids with the McrBC enzyme, which digests 375!
only methylated DNA, according to the manufacturer’s instructions (New England BioLabs). 376!
The fully methylated and non-methylated plasmids were microinjected into the cytoplasm of 377!
zebrafish embryos at one- or two-cell stage following the above protocol. To visualize eGFP 378!
fluorescence in the developing embryos, 19 and/or 22hpf embryos microinjected with fully 379!
methylated and non-methylated plasmids were placed in a glass-bottomed dish and observed.  380!
We used a Leica M165 FC stereomicroscope equipped with a DFC310FX camera (Leica). 381!
Fluorescence images of live embryos were captured and analyzed using Leica Application Suite 382!
(LAS) software. The fluorescence intensity in all embryos was measured at the indicated stages 383!
using ImageJ software (National Institute of Heatlh, NIH) and displayed as vertical bar chart 384!
(Burgess et al., 2010). To exclude the possible effect of vector backbone CpG-methylation on the 385!
eGFP reporter gene expression, a CpG-free promoter (0.7Kb mustn1b promoter, unpublished 386!
data) was clone into the destination vector pToleGFPDest (Lawson Lab # 274) containing the 387!
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eGFP sequence downstream and used as a positive control in the transient expression 388!
experiments. 389!
5-Aza-2’-deoxycytidine treatment  390!
5-Aza-2’-deoxycytidine (5-aza-dC) was purchased from Sigma Aldrich, Spain. A final 391!
concentration of 50 µM was used (Martin et al., 1999). Embryos were treated for 30 days with 5-392!
aza-dC with the fish water (Westerfield, 1997) being replaced every 24 h with fresh fish water 393!
containing 5-aza-dC. The application was initiated at 11 dpf and finished at 40 dpf. 394!
5’Azacytidine-2-deoxycytidine it is a cytidine analog, which it is not known to produce any 395!
general cytotoxic effects (Martin et al., 1999). 5-Aza-2’-deoxycytidine was previously diluted 396!
with acetic acid: water (1:1).  397!
Genomic DNA and RNA extraction 398!
DNA and total RNA were extracted at 40 dpf from control and 5-aza-dC-treated zebrafish larvae. 399!
Additionally, individuals for each treatment were collected, anaesthetized with MS-222 (Sigma–400!
Aldrich, Madrid, Spain), and photographs were taken with a Leica DFC310 FX camera and 401!
Leica M165FC stereomicroscope. 402!
gDNA was extracted with the NucleoSpin® Tissue Kit (BD Biosciences). DNA quality was 403!
verified by electrophoresis on 1% agarose gels. Total RNA was extracted from zebrafish larvae 404!
with TrizolReagent (Ambion), and first-strand cDNA was synthesized according to the Maxima 405!
First Strand cDNA Synthesis Kit (Fermentas) protocol with 1 µg RNA. 406!
 407!
Methylation-sensitive amplification polymorphism (MSAP) genotyping 408!
A modification of the MSAP method described by (Reyna-Lopez t al., 1997) and (Xu et al., 409!
2000) was used. In brief, genomic DNA was digested with two methylation-sensitive 410!
isoschizomers (MspI and HpaII) as frequent cutters, each in combination with the same rare 411!
cutter (EcoRI) in parallel batches, ligation of adaptors and selective PCR amplification with 412!
primers complementary to the adaptors but with unique 3’ overhangs. The two isoschizomers 413!
recognize the same sequence (5’-CCGG) but differ in their sensitivity to DNA methylation. 414!
Comparison of the two profiles for each individual allowed assessment of the methylation state 415!
of the restriction sites. Methylated CpG are restricted by MspI, and hemiMethylated CpCpG sites 416!
are restricted by HpaII (REBASE). Sites that are hypermethylated (i.e. at both the internal and 417!
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external Cs) and sites that are fully methylated at the external Cs (i.e. on both strands) are not cut 418!
by either enzyme, whereas sites that are free from methylation are restricted by both.  419!
Two primer combinations (EcoRI-AAG- HpaII -TC, EcoRI -ACT- HpaII -TC) were used for 420!
selective amplifications. Primer sequences and PCR details are available in (Moran and Perez-421!
Figueroa, 2011) HpaII primers were end-labelled with a 6-FAM reporter molecule. PCR 422!
products were loaded simultaneously with a GeneScan 500 ROX size standard into an ABI 423!
Prism 310 Genetic Analyzer (Applied Biosystems). Fragment analysis and scoring was 424!
performed with GeneMapper v.3.7 software (Applied Biosystems). DNA fragments shorter than 425!
100 bp, longer than 500 bp or less than 70 relative fluorescent units were excluded from the 426!
analysis. 427!
 428!
Methylation analyses of sparc CpG island by bisulfite-mediated genomic sequencing 429!
One microgram of genomic DNA was used for bisulfited DNA conversion, according to the 430!
manufacturer's protocol (EZ DNA Methylation-DirectTM Kit, Zymo Research). Primers were 431!
designed to amplify a 300-bp fragment in the sparc intron 1, where a CpG island was detected 432!
with MethPrimer software. Primer F: 5'-AATTAAAAGGAAGAGAGATTTTTGG-3' and 433!
primer R: 5' -TCAAACCACCAAACCTACTCTA-3' were used. Two microlitres of bisulfited 434!
DNA were taken for the PCR reaction. DreamTaq MasterMix (Fermentas) was used to amplify 435!
the fragment. Bands were gel-purified and cloned into PGem-Teasy (Promega). Five individuals 436!
and 10 clones of each individual per treatment were taken and sequenced with SP6. A total of 437!
100 clones were analyzed. Using the program BDPC DNA methylation analysis platform 438!
(available at: http://biochem.jacobs-university.de/BDPC/) (Rohde et al., 2010), different 439!
methylation levels of CpG dinucleotides were computed. 440!
 441!
Quantification of sparc gene expression by real-time RT-PCR 442!
cDNA was made from total RNA with superscript III (Invitrogen) according to the 443!
manufacturer’s recommendations. The primers designed to detect sparc transcripts were: 444!
OsteoRT (F): 5’-CCCTCTGCGTGCTCCTCTTA-3’ and OsteoRT (R): 5’-445!
GCATCGCACTGCTCAAAGAA-3’. Expression levels were standardized to 18S by the 2-ΔΔT 446!
method (Livak and Schmittgen, 2001). Dilutions of 1:10 of cDNAs were made for quantifying 447!
the number of sparc transcripts. Real-time quantitative PCR (qPCR) reactions were performed in 448!
an AB 7300 real-time PCR System (Applied Biosystems) and incorporation of Maxima® SYBR 449!
Green/ROX qPCR Master Mix (2X) (Fermentas). The two-step cycling conditions for the two 450!
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primer sets were: denaturation at 95 ºC for 10 min, followed by 40 cycles at 95 ºC for 15 s and 451!
60 ºC for 1 min. All samples were done in triplicate. Finally, a melting-curve analysis was 452!
carried out at 95 ºC for 15 s, 60 ºC for 30 s and 95 ºC for 15 s for testing the specificity of the 453!
primers.  454!
 455!
Statistical analysis 456!
MSAP profiles, pooled from both primer combinations, were analysed using the R package 457!
MSAP ((Perez-Figueroa, 2013), http://msap.r-forge.r-project.org). We scored the MSAP 458!
fragments as follows: fragments present in both EcoRI-HpaII and EcoRI-MspI products (1/1), 459!
denoting a non-methylated state; those fragments present only in either EcoRI-HpaII (1/0) or 460!
EcoRI-MspI (0/1) products, corresponding to a methylated state; or absent from both EcoRI-461!
HpaII and EcoRI-MspI products (0/0), which we considered as an hyper-methylation of the 462!
target. Individual fragments (loci) were, therefore, classified into ‘methylation-susceptible loci' 463!
(MSL) if the observed proportion of methylated scores (1/0, 0/1 and 0/0) exceeded a 5%, and 464!
“methylation-susceptible fragments” if the methylated state was the dominant marker (1 for the 465!
methylated state and 0 for the non-methylated state). Epigenetic differentiation among treatmets 466!
was assessed by means of principal coordinates analysis (PCoA) followed by analyses of 467!
molecular variance (AMOVA; (Excoffier et al., 1992)). Student's t test was used to test 468!
differences in methylation levels on sparc CpG islands and also to test the significant 469!
significance of differences in sparc levels between treatments. Statistical software of Statistical 470!
Package for the Social Sciences (IBM SPSS Statistics 2.1) was used for statistical analyses.  471!
Differences were considered statistically significant at p < 0,05. 472!
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LEGEND TO THE FIGURES 578!
 579!
Figure 1. Sparc transgene constructs and the eGFP expression in zebrafish. A) A schematic 580!
diagram of the zebrafish sparc locus shows the exons and approximately 7,25 kb of the genomic 581!
region upstream of sparc. B) Sparc-iTol2-eGFP-BAC: eGFP modified BAC showing reporter 582!
eGFP gene inserted before sparc translational start codon. C) 7,25kb-sparc-Tol2-eGFP: Tol2 583!
eGFP reporter gene construct contains a promoter region spanning nt −127 to the transcription 584!
start site (+1), the first exon, the unique intron of the 5′-UTR of the gene and a small part of the 585!
second exon. D) 0,25kb-sparc-Tol2-eGFP is an eGFP reporter gene construct having a deletion 586!
of the non-coding intron 1-2 sequence. (E-I) eGFP expression in zebrafish carring a modified 587!
BAC construct (Sparc-iTol2-eGFP-BAC) and/or a Tol2 eGFP reporter gene construct (7,25kb-588!
sparc-Tol2-eGFP). Observed fluorescence from both construct was equivalent. Expression of 589!
eGFP(green) together with 4,6-diamidino-2-phenylindole (DAPI) (blue) was analyzed at the 590!
indicated developmental stages. (E) At 19 hpf, periodic expression of eGFP is detected in the 591!
notochord (arrows). At 30dpf, eGFP is expressed in a broad domain that contains most of the 592!
pharyngeal region (F), otic vesicle (F) (inset is a magnified image of the otic vesicle), fin fold 593!
(G) and intermediate cell mass (H). At 48hpf, eGFP is detected in the olfactory sensory neurons 594!
within the olfactory placode (I, inset is a magnified image of the olfactory placode, showing the 595!
olfactory sensory neurons and the olfactory epithelium). (J,K,L) Whole mount in situ 596!
hybridization shows sparc mRNA expressed in zebrafish notochord (periodic expression, 597!
arrows), pharyngeal region, otic vesicle, find fold and hematopoietic ICM region at 19, 25 and 598!
40 hpf stages. Lateral views with anterior to the left and dorsal to the top. Abbreviations: E, 599!
exon; i, intron; n, notochord; pr, pharyngeal region; ov, otic vesicle; ff, fin fold; e, eye;op, 600!
olfactory placode; osn, olfactory sensory neurons; oe, olfactory epithelium; icm, intermediate 601!
cell mass;  Scale bars: 100µm. Black boxes indicate untranslated regions; open boxes indicate 602!
coding exons; lollipops indicate CpG island detected. 603!
 604!
Figure 2. Genoma-wide DNA methylation changes in control and 5-aza-dC-treated juvenile 40 605!
dpf zebrafish. Principal Coordinates Analysis (PCoA) results for epigenetic differentiation 606!
between control and 5’-azacytidine-treated juvenile 40 dpf zebrafish. The two coordinates (C1 607!
and C2) show the percentage variance in parentheses. (!) represents control fish while (") 608!
represents 5-aza-dC-treated larvae. Group’s labels show the centroid for the points cloud in each 609!
group. Ellipses represent the dispersion of each group around its centre. The long axis of the 610!
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ellipse shows the direction of maximum dispersion and the short axis, the direction of minimum 611!
dispersion.  612!
 613!
Figure 3. Methylation patterns of zebrafish Sparc putative promoter at 40dpf. A) A schematic 614!
depiction of the zebrafish Sparc gene, including the CpG island and the relative location of the 615!
PCR amplicon between positions −6634 and −6905. B) The sequence of the PCR amplicon, 616!
including the positions of the nine CpG sites. C) Resulting differences in zebrafish Sparc  617!
promoter DNA methylation in 40dpf according to 5-aza-dC treatment.  On the left, one fish 618!
representative of the level of methylation is shown per each treatment.  Open and filled circles 619!
denote unmethylated and methylated positions, respectively. Ten clones per fish were analyzed. 620!
Average methylation was calculated specifically for each CpG position(number below each 621!
column).Numbers with a positive sign indicate CpG positions in respect to the transcription 622!
starting site. On the right, percentage of methylated CpGs in both groups. Data are expressed as 623!
mean ± SEM. Statistically significant differences (p<0.05) are indicated by asterisks (*).  624!
 625!
Figure 4. Effects of methylation on zebrafish sparc promoter activity in vitro. Zebrafish 626!
embryos were microinjected with 7,25kb-sparc-Tol2-eGFP or 0,7kb-Musnt1-Tol2-eGFP 627!
methylated (B,D) and unmethylated (A,C) promoter vectors.  Microinjected methylated and 628!
unmethylated groups were as follows: 1) zebrafish 7,5Kb Sparc promoter cloned into 629!
pTolEGFPDest reporter plasmid (7,25kb-sparc-Tol2-eGFP) (A,B); 2) zebrafish  0,75Kb Mustnt1 630!
promoter cloned into pTolEGFPDest reporter plasmid (0,7kb-Mustn1b-Tol2-eGFP) (Ctrl, CpG-631!
free Promoter) (C,D). E, intensity of eGFP fluorescent measurements were performed with 632!
Image J and displayed as vertical bar chart. Student t tests were performed to determine 633!
statistical relevance. Values are shown as mean ± S.E.M. (n = 10). E Inset: Successful vector 634!
methylation verification by analysis of band patterns on electrophoresis gel after digestion of the 635!
purified plasmids with the McrBC enzyme. Lane M, 1 Kb marker; lane 1 and 5 1 µg 7,25kb-636!
sparc-Tol2-eGFP or 0,7kb-mustn1b-Tol2-eGFP; lane 2 and 6 1 µg 7,25kb-sparc-Tol2-eGF or 637!
0,7kb-mustn1b-Tol2-eGFP treated with McrBC; lane 3 and 7 1 µg SssI-methylated 7,25kb-sparc-638!
Tol2-eGFP or 0,7kb-mustn1b-Tol2-eGFP; lane 4 and 8, 1 µg SssI-methylated 7,25kb-sparc-639!
Tol2-eGFP or 0,7kb-mustn1b-Tol2-eGFP treated with McrBC. As expected, only the methylated 640!
vector was digested. Scale bars: 250µm. 641!
 642!
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 643!
Supplementary data 644!
 645!
Figure 1S. Expression of sparc in response to 5-aza-dC treatment. The relative expression of 646!
sparc was determined by real-time PCR and standardized to 18S. The results are expressed as 647!
mean ± SEM with respect to the control, which was set at 1. Statistically significant differences 648!
(p<0.05) are indicated by asterisks (*). 649!
 650!
 651!
Table 1. Percentage of each methylation state in control and 5-aza-dC groups 652!
 653!
 HPA+/MSP+ 
(Unmethylated) 
HPA+/MSP- 
(Hemi-methylated) 
HPA-/MSP+ 
(Internal C methylation) 
HPA-/MSP- 
(Full methylation) 
Control       16.6 9.4 31 43 
5-aza-dC 41.6 10.2 17.1 31.1 
 654!
 655!
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